Ripon College working with Eli Lilly to screen molecules for potential pharmaceutical use
Ripon College now is affiliated with the Open Innovation Drug Discovery Program at Eli Lilly. Through this program, students and faculty will use the technology at Eli Lilly to virtually screen molecules for their potential to be pharmaceuticals. After virtual screening, students and faculty will send molecules prepared at Ripon College to Eli Lilly for actual biological testing.
This program allows students and faculty to use their research to directly participate in the discovery of new pharmaceuticals. For example, several students in Assistant Professor of Chemistry Patrick Willoughby’s research lab have synthesized many completely new molecules. These molecules now can be assessed for their viability to treat disease and other ailments.
“I am excited to see student research at Ripon College directly contribute to the discovery of new drugs,” Willoughby says. “This undoubtedly will enhance their understanding of modern medicine and positively affect the prospect of them pursuing a career in health sciences.”
The Ripon College Center for Diversity and Inclusion has announced its spring calendar of events. Visit here to view the scheduled month-by-month offerings. The center […]
Adjunct Instructor of Digital Art Christopher T. Wood is a candidate for the prestigious Pfister Hotel Artist-in-Residence in Milwaukee. Candidates for the award will have […]
Research by Erin K. Bryan, assistant professor of music and voice area coordinator, has been selected for a poster paper presentation at the 2022 National […]
Ripon Hall of Fame Coach Bob Gillespie will be inducted into Lewis University’s Academy of Coaches. He will be honored with three others during halftime […]